Joshua A. Kazam, Director at CAPRICOR THERAPEUTICS, INC. (CAPR), bought 7,096 shares at $3.52 ($25K) on 2015-01-21, disclosed to the SEC on 2015-01-22.
Open-market purchase of $25k CAPR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| EAGL | BUY | 2019-03-01 | $101K | — | Filing → |
| NLTX | BUY | 2009-03-13 | $383 | — | Filing → |
| NLTX | BUY | 2008-12-16 | $4K | — | Filing → |